VRDN
Viridian Therapeutics, Inc.\DE
-0.42 (-1.87%)22.02USD382K成交股數2.5B市值–本益比(近四季)35.1股價營收比+278.7%營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 2 · 348K · 1 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 60.0M · 348K |
| 近 180 天 淨額 | 59.7M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-19 | 08-20 | Tousignant Jennifer | Chief Legal Officer | S 公開市場賣出 | 10.0K | 24.50 | 245K | 0 | SEC |
| 2026-08-19 | 08-20 | Tousignant Jennifer | Chief Legal Officer | S 公開市場賣出 | 4.2K | 24.50 | 103K | 0 | SEC |
| 2026-08-19 | 08-20 | Tousignant Jennifer | Chief Legal Officer | M 選擇權執行 | 10.0K | 14.41 | 144K | 10.0K | SEC |
| 2026-08-14 | 08-18 | Tripuraneni Radhika | Chief Medical Officer | M 選擇權執行 | 40.0K | 13.21 | 528K | 40.0K | SEC |
| 2026-05-11 | 05-13 | Fairmount Healthcare Fund II GP LLC | Director,TenPercentOwner | P 公開市場買進 | 1.2M | 17.00 | 20.0M | 5.1M | SEC |
| 2026-05-11 | 05-13 | Fairmount Healthcare Fund II L.P. | Director,TenPercentOwner | P 公開市場買進 | 1.2M | 17.00 | 20.0M | 5.1M | SEC |
| 2026-05-11 | 05-13 | Fairmount Funds Management LLC | Director,TenPercentOwner | P 公開市場買進 | 1.2M | 17.00 | 20.0M | 5.1M | SEC |
| 2026-03-03 | 03-09 | Beetham Thomas W. | Chief Operating Officer | F 繳稅扣股 | 3.0K | 30.19 | 92K | 13.4K | SEC |
| 2026-03-03 | 03-09 | Harmon Seth | Chief Financial Officer | F 繳稅扣股 | 2.0K | 30.19 | 61K | 7.8K | SEC |
| 2026-03-03 | 03-09 | Tousignant Jennifer | Chief Legal Officer | F 繳稅扣股 | 1.7K | 30.19 | 51K | 3.5K | SEC |
| 2026-03-03 | 03-09 | Mahoney Stephen F. | President and CEO | F 繳稅扣股 | 7.4K | 30.19 | 224K | 33.3K | SEC |
| 2026-03-03 | 03-04 | Beetham Thomas W. | Chief Operating Officer | M 選擇權執行 | 9.4K | – | – | 16.4K | SEC |
| 2026-03-03 | 03-04 | Mahoney Stephen F. | President and CEO | M 選擇權執行 | 18.4K | – | – | 40.8K | SEC |
| 2026-03-03 | 03-04 | Beetham Thomas W. | Chief Operating Officer | F 繳稅扣股 | 3.1K | 29.32 | 92K | 13.3K | SEC |
| 2026-03-03 | 03-04 | Mahoney Stephen F. | President and CEO | F 繳稅扣股 | 7.6K | 29.32 | 224K | 33.1K | SEC |
| 2026-03-03 | 03-04 | Harmon Seth | Chief Financial Officer | M 選擇權執行 | 6.3K | – | – | 9.9K | SEC |
| 2026-03-03 | 03-04 | Tousignant Jennifer | Chief Legal Officer | F 繳稅扣股 | 1.7K | 29.32 | 51K | 3.4K | SEC |
| 2026-03-03 | 03-04 | Tousignant Jennifer | Chief Legal Officer | M 選擇權執行 | 5.2K | – | – | 5.2K | SEC |
| 2026-03-03 | 03-04 | Harmon Seth | Chief Financial Officer | F 繳稅扣股 | 2.1K | 29.32 | 61K | 7.8K | SEC |
| 2025-12-31 | 01-02 | Tousignant Jennifer | Chief Legal Officer | S 公開市場賣出 | 2.3K | 31.16 | 71K | 0 | SEC |
| 2025-10-23 | 10-27 | Fairmount Healthcare Fund II L.P. | Director,TenPercentOwner | P 公開市場買進 | 455K | 22.00 | 10.0M | 3.9M | SEC |
| 2025-10-23 | 10-27 | Fairmount Healthcare Fund II GP LLC | Director,TenPercentOwner | P 公開市場買進 | 455K | 22.00 | 10.0M | 3.9M | SEC |
| 2025-10-23 | 10-27 | Fairmount Funds Management LLC | Director,TenPercentOwner | P 公開市場買進 | 455K | 22.00 | 10.0M | 3.9M | SEC |
| 2025-06-10 | 06-11 | Fairmount Healthcare Fund II GP LLC | Director,TenPercentOwner | M 選擇權執行 | 12.5K | 12.31 | 154K | 3.5M | SEC |
| 2025-06-10 | 06-11 | Fairmount Funds Management LLC | Director,TenPercentOwner | M 選擇權執行 | 12.5K | 12.31 | 154K | 3.5M | SEC |
| 2025-06-10 | 06-11 | Fairmount Healthcare Fund II L.P. | Director,TenPercentOwner | M 選擇權執行 | 12.5K | 12.31 | 154K | 3.5M | SEC |
| 2025-06-09 | 06-11 | Fairmount Funds Management LLC | Director,TenPercentOwner | M 選擇權執行 | 1.6K | 7.80 | 12K | 3.4M | SEC |
| 2025-06-09 | 06-11 | Fairmount Healthcare Fund II L.P. | Director,TenPercentOwner | M 選擇權執行 | 1.6K | 7.80 | 12K | 3.4M | SEC |
| 2025-06-09 | 06-11 | Fairmount Healthcare Fund II GP LLC | Director,TenPercentOwner | M 選擇權執行 | 1.6K | 7.80 | 12K | 3.4M | SEC |
| 2024-09-27 | 09-30 | Beetham Thomas W. | Chief Operating Officer | P 公開市場買進 | 5.0K | 23.41 | 117K | 6.0K | SEC |
| 2024-09-27 | 09-30 | Mahoney Stephen F. | President and CEO | P 公開市場買進 | 21.4K | 23.33 | 499K | 21.4K | SEC |
| 2024-09-13 | 09-17 | Fairmount Healthcare Fund II L.P. | Director,TenPercentOwner | P 公開市場買進 | 1.6M | 18.75 | 30.0M | 3.4M | SEC |
| 2024-09-13 | 09-17 | Fairmount Funds Management LLC | Director,TenPercentOwner | P 公開市場買進 | 1.6M | 18.75 | 30.0M | 3.4M | SEC |
| 2024-09-13 | 09-17 | Fairmount Healthcare Fund II GP LLC | Director,TenPercentOwner | P 公開市場買進 | 1.6M | 18.75 | 30.0M | 3.4M | SEC |
| 2024-03-28 | 04-01 | Fairmount Funds Management LLC | Director,TenPercentOwner | J 其他 | 5.9K | – | – | 1.8M | SEC |
| 2024-03-28 | 04-01 | Fairmount Healthcare Fund L.P. | Director | J 其他 | 5.9K | – | – | 1.8M | SEC |
| 2024-03-28 | 04-01 | Fairmount Healthcare Fund GP LLC | Director | J 其他 | 5.9K | – | – | 1.8M | SEC |
| 2024-03-28 | 04-01 | Fairmount Healthcare Fund L.P. | Director | J 其他 | 5.9K | – | – | 0 | SEC |
| 2024-03-28 | 04-01 | Fairmount Healthcare Fund GP LLC | Director | J 其他 | 5.9K | – | – | 0 | SEC |
| 2024-03-28 | 04-01 | Fairmount Healthcare Fund II GP LLC | Director,TenPercentOwner | J 其他 | 5.9K | – | – | 1.8M | SEC |
| 2024-03-28 | 04-01 | Fairmount Healthcare Fund II GP LLC | Director,TenPercentOwner | J 其他 | 5.9K | – | – | 0 | SEC |
| 2024-03-28 | 04-01 | Fairmount Funds Management LLC | Director,TenPercentOwner | J 其他 | 5.9K | – | – | 0 | SEC |
| 2024-03-28 | 04-01 | Fairmount Healthcare Fund II L.P. | Director,TenPercentOwner | J 其他 | 5.9K | – | – | 1.8M | SEC |
| 2024-03-28 | 04-01 | Fairmount Healthcare Fund II L.P. | Director,TenPercentOwner | J 其他 | 5.9K | – | – | 0 | SEC |
| 2024-01-22 | 01-24 | Fairmount Healthcare Fund L.P. | Director,Other | P 公開市場買進 | 476K | 21.00 | 10.0M | 1.8M | SEC |
| 2024-01-22 | 01-24 | Fairmount Healthcare Fund GP LLC | Director,Other | P 公開市場買進 | 476K | 21.00 | 10.0M | 1.8M | SEC |
| 2024-01-22 | 01-24 | Fairmount Healthcare Fund II GP LLC | Director,TenPercentOwner,Other | P 公開市場買進 | 476K | 21.00 | 10.0M | 1.8M | SEC |
| 2024-01-22 | 01-24 | Fairmount Funds Management LLC | Director,TenPercentOwner,Other | P 公開市場買進 | 476K | 21.00 | 10.0M | 1.8M | SEC |
| 2024-01-22 | 01-24 | Fairmount Healthcare Fund II L.P. | Director,TenPercentOwner,Other | P 公開市場買進 | 476K | 21.00 | 10.0M | 1.8M | SEC |
| 2023-06-16 | 06-20 | Meisner Lara | Chief Legal Officer | M 選擇權執行 | 27 | 23.03 | 621.81 | 30.0K | SEC |
| 2023-06-16 | 06-20 | Meisner Lara | Chief Legal Officer | S 公開市場賣出 | 27 | 28.35 | 765.45 | 30.0K | SEC |
| 2023-06-15 | 06-20 | Meisner Lara | Chief Legal Officer | S 公開市場賣出 | 2.3K | 28.02 | 64K | 30.0K | SEC |
| 2023-06-15 | 06-20 | Meisner Lara | Chief Legal Officer | M 選擇權執行 | 2.3K | 23.03 | 52K | 32.2K | SEC |
| 2023-06-06 | 06-06 | Meisner Lara | Chief Legal Officer | S 公開市場賣出(10b5-1) | 5.1K | 25.02 | 128K | 30.0K | SEC |
| 2023-06-06 | 06-06 | Meisner Lara | Chief Legal Officer | M 選擇權執行 | 5.1K | 18.51 | 95K | 35.1K | SEC |
| 2023-06-05 | 06-06 | Meisner Lara | Chief Legal Officer | M 選擇權執行 | 499 | 18.51 | 9K | 30.5K | SEC |
| 2023-06-05 | 06-06 | Meisner Lara | Chief Legal Officer | S 公開市場賣出(10b5-1) | 499 | 25.03 | 12K | 30.0K | SEC |
| 2023-06-02 | 06-06 | Meisner Lara | Chief Legal Officer | M 選擇權執行 | 1.9K | 14.00 | 26K | 31.8K | SEC |
| 2023-06-02 | 06-06 | Meisner Lara | Chief Legal Officer | S 公開市場賣出(10b5-1) | 1.9K | 24.21 | 45K | 30.0K | SEC |
| 2023-04-12 | 04-12 | Myers Scott Dunseth | Chief Executive Officer | P 公開市場買進 | 4.0K | 25.37 | 101K | 260K | SEC |
| 2023-03-13 | 03-13 | Myers Scott Dunseth | Chief Executive Officer | P 公開市場買進 | 5.5K | 29.15 | 160K | 256K | SEC |
| 2023-03-09 | 03-10 | Meisner Lara | General Counsel and Secretary | S 公開市場賣出 | 30.0K | 29.07 | 871K | 0 | SEC |
| 2023-02-06 | 02-07 | Myers Scott Dunseth | Chief Executive Officer | A 獲配股票 | 250K | – | – | 250K | SEC |
| 2023-02-02 | 02-07 | Violin Jonathan | Chief Executive Officer | M 選擇權執行 | 50.0K | 0.15 | 8K | 531K | SEC |
| 2023-02-02 | 02-07 | Violin Jonathan | Chief Executive Officer | S 公開市場賣出 | 50.0K | 36.80 | 1.8M | 481K | SEC |
| 2023-02-02 | 02-03 | Violin Jonathan | Chief Executive Officer | S 公開市場賣出 | 50.0K | 36.80 | 1.8M | 431K | SEC |
| 2023-01-23 | 01-25 | Meisner Lara | General Counsel and Secretary | M 選擇權執行 | 5.0K | 23.03 | 114K | 5.0K | SEC |
| 2023-01-23 | 01-25 | Meisner Lara | General Counsel and Secretary | S 公開市場賣出 | 6.8K | 35.66 | 244K | 0 | SEC |
| 2023-01-23 | 01-25 | Meisner Lara | General Counsel and Secretary | M 選擇權執行 | 1.9K | 14.00 | 26K | 6.8K | SEC |
| 2023-01-17 | 01-18 | Katz Barrett | Chief Medical Officer | S 公開市場賣出 | 24.9K | 37.21 | 925K | 0 | SEC |
| 2023-01-17 | 01-18 | Katz Barrett | Chief Medical Officer | M 選擇權執行 | 24.9K | 23.03 | 572K | 24.9K | SEC |
| 2023-01-13 | 01-18 | Katz Barrett | Chief Medical Officer | M 選擇權執行 | 4.1K | 23.03 | 96K | 4.1K | SEC |
| 2023-01-13 | 01-18 | Katz Barrett | Chief Medical Officer | S 公開市場賣出 | 4.1K | 37.01 | 153K | 0 | SEC |
| 2023-01-10 | 01-11 | Katz Barrett | Chief Medical Officer | S 公開市場賣出 | 47.4K | 35.30 | 1.7M | 0 | SEC |
| 2023-01-10 | 01-11 | Katz Barrett | Chief Medical Officer | M 選擇權執行 | 47.4K | 23.03 | 1.1M | 47.4K | SEC |
| 2023-01-09 | 01-11 | Katz Barrett | Chief Medical Officer | S 公開市場賣出 | 12.6K | 33.04 | 417K | 0 | SEC |
| 2023-01-09 | 01-11 | Katz Barrett | Chief Medical Officer | M 選擇權執行 | 12.6K | 23.03 | 291K | 12.6K | SEC |
| 2022-12-21 | 12-22 | Meisner Lara | General Counsel and Secretary | M 選擇權執行 | 16.3K | 23.03 | 376K | 16.3K | SEC |
| 2022-12-21 | 12-22 | Meisner Lara | General Counsel and Secretary | S 公開市場賣出 | 16.3K | 29.19 | 477K | 0 | SEC |
| 2022-12-20 | 12-22 | Meisner Lara | General Counsel and Secretary | S 公開市場賣出 | 600 | 28.07 | 17K | 0 | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| FMR LLC | 16.6M | 305M | 新進 | 新進 |
| BlackRock, Inc. | 8.6M | 157M | 新進 | 新進 |
| Bellevue Group AG | 6.7M | 124M | 新進 | 新進 |
| Paradigm Biocapital Advisors LP | 6.7M | 124M | 新進 | 新進 |
| Kynam Capital Management, LP | 6.5M | 119M | 新進 | 新進 |
| STATE STREET CORP | 6.1M | 113M | 新進 | 新進 |
| Fairmount Funds Management LLC | 5.1M | 93.5M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.6M | 84.1M | 新進 | 新進 |
| Deep Track Capital, LP | 3.6M | 66.0M | 新進 | 新進 |
| Venrock Adviser, LLC | 3.3M | 59.8M | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.1M | 57.5M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.8M | 50.6M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5M | 46.0M | 新進 | 新進 |
| Avoro Capital Advisors LLC | 2.5M | 45.9M | 新進 | 新進 |
| BAKER BROS. ADVISORS LP | 2.4M | 43.8M | 新進 | 新進 |
| Point72(柯恩) Point72 Asset Management, L.P. | 2.3M | 43.0M | 新進 | 新進 |
| Caligan Partners LP | 2.2M | 40.3M | 新進 | 新進 |
| NOVO HOLDINGS A/S | 2.1M | 39.2M | 新進 | 新進 |
| TANG CAPITAL MANAGEMENT LLC | 1.8M | 32.9M | 新進 | 新進 |
| Fisher Asset Management, LLC | 1.8M | 32.2M | 新進 | 新進 |
| Candriam S.C.A. | 1.7M | 31.3M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 1.7M | 31.1M | 新進 | 新進 |
| First Turn Management, LLC | 1.7M | 30.7M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 1.6M | 29.6M | 新進 | 新進 |
| ALLIANCEBERNSTEIN L.P. | 1.4M | 27.2M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 214 -12 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 214 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 136M · 100.0% |
| 合計季末市值 | 2.4B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 19.5M |
|---|---|
| 與上期比 | +2.5% |
| 佔流通股數 | 17.22% |
| 日均成交量 | 1.2M |
| 回補天數 | 16.6 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 19.5M | +2.5% | 17.22% | 1.2M | 16.6 |
| 2026-08-14 | 19.0M | -1.1% | 16.79% | 2.1M | 9.1 |
| 2026-07-31 | 19.2M | +1.6% | 16.98% | 1.7M | 11.3 |
| 2026-07-15 | 18.9M | +9.1% | 16.70% | 1.9M | 9.9 |
| 2026-06-30 | 17.3M | +15.5% | 15.31% | 3.1M | 5.6 |
| 2026-06-15 | 15.0M | +2.9% | 13.26% | 1.5M | 10.1 |
| 2026-05-29 | 14.6M | +2.3% | 12.88% | 1.8M | 7.9 |
| 2026-05-15 | 14.3M | +23.9% | 12.59% | 4.7M | 3.1 |
| 2026-04-30 | 11.5M | +8.0% | 10.16% | 1.7M | 6.9 |
| 2026-04-15 | 10.7M | -1.7% | 9.41% | 4.1M | 2.6 |
| 2026-03-31 | 10.8M | +31.7% | 9.57% | 2.7M | 4.0 |
| 2026-03-13 | 8.2M | +5.3% | 7.27% | 1.1M | 7.3 |
| 2026-02-27 | 7.8M | +0.8% | 6.90% | 1.3M | 6.0 |
| 2026-02-13 | 7.8M | -2.2% | 6.85% | 1.4M | 5.6 |
| 2026-01-30 | 7.9M | -2.6% | 7.01% | 1.5M | 5.4 |
| 2026-01-15 | 8.1M | -6.1% | 7.19% | 1.6M | 5.2 |
| 2025-12-31 | 8.7M | -4.0% | 7.66% | 1.4M | 6.0 |
| 2025-12-15 | 9.0M | -1.5% | 7.98% | 1.4M | 6.5 |
| 2025-11-28 | 9.2M | -3.1% | 8.10% | 1.8M | 5.0 |
| 2025-11-14 | 9.5M | -3.0% | 8.36% | 2.1M | 4.6 |
| 2025-10-31 | 9.8M | -2.3% | 8.62% | 1.8M | 5.4 |
| 2025-10-15 | 10.0M | -2.4% | 8.82% | 850K | 11.8 |
| 2025-09-30 | 10.2M | -7.0% | 9.03% | 642K | 16.0 |
| 2025-09-15 | 11.0M | -4.9% | 9.71% | 892K | 12.3 |
| 2025-08-29 | 11.6M | -1.8% | 10.21% | 848K | 13.6 |
| 2025-08-15 | 11.8M | +1.0% | 10.40% | 841K | 14.0 |